PBMC-derived FGF, PDGF, VEGF and GM-CSF secretion in endometriosis: a case–control in vitro study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

In Vitro Analysis of FGF, PDGF, VEGF, and GM-CSF Production by PBMCs in Endometriosis: A Case-Control Study

  • By

  • Marcin Sadlocha

  • Aleksandra Krzywon

  • Jakub Marcin Staniczek

  • Jakub Toczek

  • Zenon Czuba

  • Rafal Stojko

  • June 4, 2026

Share

Clinical Scorecard: In Vitro Analysis of FGF, PDGF, VEGF, and GM-CSF Production by PBMCs in Endometriosis: A Case-Control Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingClinical research setting focused on endometriosis.

Key Highlights

  • Clarify significance of findings regarding baseline secretion.

Guideline-Based Recommendations

Diagnosis

    Management

    • Hormonal therapy, surgical excision, and consideration of pain management strategies.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Current treatments provide symptomatic relief but may have side effects such as hormonal imbalances.

        Clinical Best Practices

        • Consider immune dysregulation in the management of endometriosis, supported by recent studies.

        Related Resources & Content

        Original Source(s)

        PBMC-derived FGF, PDGF, VEGF and GM-CSF secretion in endometriosis: a case–control in vitro study

        • by Marcin Sadlocha, Aleksandra Krzywon, Jakub Marcin Staniczek, Jakub Toczek, Zenon Czuba, Rafal Stojko

        • June 4, 2026

        Related Content

        Ovarian endometriosis associated with significantly elevated CA19-9: a case report

        Bioinformatics and machine learning-driven discovery of candidate tissue diagnostic markers for endometriosis with experimental verification

        Top 10 States for Physician-Owned Hospitals

        These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.